Smokers' behavioral intentions in response to a low-nicotine cigarette policy.


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 12 2019
Historique:
received: 01 07 2019
revised: 28 08 2019
accepted: 19 09 2019
pubmed: 11 11 2019
medline: 1 7 2020
entrez: 10 11 2019
Statut: ppublish

Résumé

Evidence suggests that reducing the nicotine concentration in cigarettes to sub-addictive levels would reduce use. Until a low-nicotine cigarette policy is enacted, population-level effects are unknown. This study examines the behavioral intentions of current U.S. cigarette smokers if a low-nicotine policy were implemented. Data were drawn from a nationally representative probability-based panel and opt-in panel. Weighted logistic regressions examined likelihood to (1) smoke lower nicotine cigarettes, (2) quit using tobacco, (3) use e-cigarettes, (4) illegally buy high-nicotine cigarettes, and (5) smoke cigars, cigarillos, or little cigars (CLCCs) among smokers, controlling for demographics, tobacco products used, dependence, and intentions to quit cigarettes. Latent class analyses (LCA) characterized patterns of behavioral intentions. If a low-nicotine policy were implemented, most participants indicated a likelihood to smoke low-nicotine cigarettes (78.4%) or quit tobacco (61.9%), followed by use e-cigarettes (46.5%). Individuals with greater dependence had greater odds of intending to smoke low-nicotine cigarettes, use e-cigarettes, and illegally buy high-nicotine cigarettes. Current e-cigarette or CLCCs users had higher odds of intending to use these products. LCA revealed that individuals would 1) use low-nicotine cigarettes with low intentions to use other tobacco products or 2) use multiple tobacco products, including low-nicotine cigarettes. A reduced nicotine standard for all combustible tobacco products is needed given that many tobacco users would likely intend to continue to use tobacco products. Differences in intentions by tobacco use and demographic characteristics indicate a need for additional cessation support and education around the harms of continued use of combustible tobacco.

Identifiants

pubmed: 31704376
pii: S0376-8716(19)30422-3
doi: 10.1016/j.drugalcdep.2019.107645
pii:
doi:

Substances chimiques

Nicotine 6M3C89ZY6R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107645

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Minal Patel (M)

Truth Initiative Schroeder Institute, 900 G Street NW, Washington, D.C., 20001, USA. Electronic address: mpatel@truthinitiative.org.

Alison F Cuccia (AF)

Truth Initiative Schroeder Institute, 900 G Street NW, Washington, D.C., 20001, USA. Electronic address: acuccia@truthinitiative.org.

Lauren Czaplicki (L)

Truth Initiative Schroeder Institute, 900 G Street NW, Washington, D.C., 20001, USA. Electronic address: lczaplicki@truthinitiative.org.

Emily M Donovan (EM)

Truth Initiative Schroeder Institute, 900 G Street NW, Washington, D.C., 20001, USA. Electronic address: edonovan@truthinitiative.org.

Bethany Simard (B)

Truth Initiative Schroeder Institute, 900 G Street NW, Washington, D.C., 20001, USA. Electronic address: bsimard@truthinitiative.org.

Lindsay Pitzer (L)

Truth Initiative Schroeder Institute, 900 G Street NW, Washington, D.C., 20001, USA. Electronic address: lpitzer@truthinitiative.org.

Elizabeth C Hair (EC)

Truth Initiative Schroeder Institute, 900 G Street NW, Washington, D.C., 20001, USA; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Electronic address: ehair@truthinitiative.org.

Barbara A Schillo (BA)

Truth Initiative Schroeder Institute, 900 G Street NW, Washington, D.C., 20001, USA. Electronic address: bschillo@truthinitiative.org.

Donna M Vallone (DM)

Truth Initiative Schroeder Institute, 900 G Street NW, Washington, D.C., 20001, USA; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; Global Institute of Public Health, New York University, New York, NY 10012, USA. Electronic address: dvallone@truthinitiative.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH